Galecto Biotech

Developer of galectin modulators for treating idiopathic pulmonary fibrosis

placeCopenhagen, Capital Region Of Denmark, Denmark calendar_todayFounded 2010 groups29 employees language galecto.com

Registered entities

Social engagement

Social engagement: 5.4K social following, 2 posts in the last 12 months — top quartile of its industry.

Investor mix

23 investors on record; lead investors include Soleus Capital, Eir Ventures, Ysios Capital, Orbimed; 4 have since exited.

Investor typeCountShare
Venture capital1357%
Private equity313%
Accelerator & incubator14%
Other / undisclosed626%

Recent activity

6 Jan 2026
Leadership hire
Chief Operating Officer
Coming soon